HomeAGN • CNSX
add
Algernon Pharmaceuticals Inc
Previous close
$0.075
Day range
$0.075 - $0.080
Year range
$0.050 - $0.17
Market cap
1.92M CAD
Avg Volume
22.82K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | May 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 442.30K | -58.38% |
Net income | 1.44M | 228.09% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -436.21K | 58.45% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | May 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 609.52K | 40.37% |
Total assets | 3.89M | -36.55% |
Total liabilities | 1.93M | -20.02% |
Total equity | 1.96M | — |
Shares outstanding | 21.94M | — |
Price to book | 0.83 | — |
Return on assets | -28.18% | — |
Return on capital | -92.17% | — |
Cash Flow
Net change in cash
| (CAD) | May 2024info | Y/Y change |
|---|---|---|
Net income | 1.44M | 228.09% |
Cash from operations | -1.79M | -143.65% |
Cash from investing | 2.31M | 8,640.70% |
Cash from financing | 7.50K | -99.23% |
Net change in cash | 533.25K | 149.59% |
Free cash flow | -1.85M | -348.24% |
About
Founded
2015
Headquarters
Website
